Cargando…

EFICAz(2): enzyme function inference by a combined approach enhanced by machine learning

BACKGROUND: We previously developed EFICAz, an enzyme function inference approach that combines predictions from non-completely overlapping component methods. Two of the four components in the original EFICAz are based on the detection of functionally discriminating residues (FDRs). FDRs distinguish...

Descripción completa

Detalles Bibliográficos
Autores principales: Arakaki, Adrian K, Huang, Ying, Skolnick, Jeffrey
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2670841/
https://www.ncbi.nlm.nih.gov/pubmed/19361344
http://dx.doi.org/10.1186/1471-2105-10-107
_version_ 1782166329742065664
author Arakaki, Adrian K
Huang, Ying
Skolnick, Jeffrey
author_facet Arakaki, Adrian K
Huang, Ying
Skolnick, Jeffrey
author_sort Arakaki, Adrian K
collection PubMed
description BACKGROUND: We previously developed EFICAz, an enzyme function inference approach that combines predictions from non-completely overlapping component methods. Two of the four components in the original EFICAz are based on the detection of functionally discriminating residues (FDRs). FDRs distinguish between member of an enzyme family that are homofunctional (classified under the EC number of interest) or heterofunctional (annotated with another EC number or lacking enzymatic activity). Each of the two FDR-based components is associated to one of two specific kinds of enzyme families. EFICAz exhibits high precision performance, except when the maximal test to training sequence identity (MTTSI) is lower than 30%. To improve EFICAz's performance in this regime, we: i) increased the number of predictive components and ii) took advantage of consensual information from the different components to make the final EC number assignment. RESULTS: We have developed two new EFICAz components, analogs to the two FDR-based components, where the discrimination between homo and heterofunctional members is based on the evaluation, via Support Vector Machine models, of all the aligned positions between the query sequence and the multiple sequence alignments associated to the enzyme families. Benchmark results indicate that: i) the new SVM-based components outperform their FDR-based counterparts, and ii) both SVM-based and FDR-based components generate unique predictions. We developed classification tree models to optimally combine the results from the six EFICAz components into a final EC number prediction. The new implementation of our approach, EFICAz(2), exhibits a highly improved prediction precision at MTTSI < 30% compared to the original EFICAz, with only a slight decrease in prediction recall. A comparative analysis of enzyme function annotation of the human proteome by EFICAz(2 )and KEGG shows that: i) when both sources make EC number assignments for the same protein sequence, the assignments tend to be consistent and ii) EFICAz(2 )generates considerably more unique assignments than KEGG. CONCLUSION: Performance benchmarks and the comparison with KEGG demonstrate that EFICAz(2 )is a powerful and precise tool for enzyme function annotation, with multiple applications in genome analysis and metabolic pathway reconstruction. The EFICAz(2 )web service is available at:
format Text
id pubmed-2670841
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26708412009-04-21 EFICAz(2): enzyme function inference by a combined approach enhanced by machine learning Arakaki, Adrian K Huang, Ying Skolnick, Jeffrey BMC Bioinformatics Methodology Article BACKGROUND: We previously developed EFICAz, an enzyme function inference approach that combines predictions from non-completely overlapping component methods. Two of the four components in the original EFICAz are based on the detection of functionally discriminating residues (FDRs). FDRs distinguish between member of an enzyme family that are homofunctional (classified under the EC number of interest) or heterofunctional (annotated with another EC number or lacking enzymatic activity). Each of the two FDR-based components is associated to one of two specific kinds of enzyme families. EFICAz exhibits high precision performance, except when the maximal test to training sequence identity (MTTSI) is lower than 30%. To improve EFICAz's performance in this regime, we: i) increased the number of predictive components and ii) took advantage of consensual information from the different components to make the final EC number assignment. RESULTS: We have developed two new EFICAz components, analogs to the two FDR-based components, where the discrimination between homo and heterofunctional members is based on the evaluation, via Support Vector Machine models, of all the aligned positions between the query sequence and the multiple sequence alignments associated to the enzyme families. Benchmark results indicate that: i) the new SVM-based components outperform their FDR-based counterparts, and ii) both SVM-based and FDR-based components generate unique predictions. We developed classification tree models to optimally combine the results from the six EFICAz components into a final EC number prediction. The new implementation of our approach, EFICAz(2), exhibits a highly improved prediction precision at MTTSI < 30% compared to the original EFICAz, with only a slight decrease in prediction recall. A comparative analysis of enzyme function annotation of the human proteome by EFICAz(2 )and KEGG shows that: i) when both sources make EC number assignments for the same protein sequence, the assignments tend to be consistent and ii) EFICAz(2 )generates considerably more unique assignments than KEGG. CONCLUSION: Performance benchmarks and the comparison with KEGG demonstrate that EFICAz(2 )is a powerful and precise tool for enzyme function annotation, with multiple applications in genome analysis and metabolic pathway reconstruction. The EFICAz(2 )web service is available at: BioMed Central 2009-04-13 /pmc/articles/PMC2670841/ /pubmed/19361344 http://dx.doi.org/10.1186/1471-2105-10-107 Text en Copyright © 2009 Arakaki et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Methodology Article
Arakaki, Adrian K
Huang, Ying
Skolnick, Jeffrey
EFICAz(2): enzyme function inference by a combined approach enhanced by machine learning
title EFICAz(2): enzyme function inference by a combined approach enhanced by machine learning
title_full EFICAz(2): enzyme function inference by a combined approach enhanced by machine learning
title_fullStr EFICAz(2): enzyme function inference by a combined approach enhanced by machine learning
title_full_unstemmed EFICAz(2): enzyme function inference by a combined approach enhanced by machine learning
title_short EFICAz(2): enzyme function inference by a combined approach enhanced by machine learning
title_sort eficaz(2): enzyme function inference by a combined approach enhanced by machine learning
topic Methodology Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2670841/
https://www.ncbi.nlm.nih.gov/pubmed/19361344
http://dx.doi.org/10.1186/1471-2105-10-107
work_keys_str_mv AT arakakiadriank eficaz2enzymefunctioninferencebyacombinedapproachenhancedbymachinelearning
AT huangying eficaz2enzymefunctioninferencebyacombinedapproachenhancedbymachinelearning
AT skolnickjeffrey eficaz2enzymefunctioninferencebyacombinedapproachenhancedbymachinelearning